Bristol-Myers Squibb Foundation Donates Funds For Hepatitis Awareness, Prevention In China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Aimed at combating a leading cause of death in the world's most populous nation, the Bristol-Myers Squibb Foundation is setting up partnerships with public health groups across China to promote awareness and prevention of hepatitis
You may also be interested in...
Will World's Largest HCV Population Have Access To Newest Treatments?
With a large patient pool and a recent expansion of government reimbursement for costly peg-interferon therapies, China is poised to see an exponential growth in its hepatitis C virus treatment market, growing north of 80% in five years, according to a recent report by research firm Decision Resources
Will World's Largest HCV Population Have Access To Newest Treatments?
With a large patient pool and a recent expansion of government reimbursement for costly peg-interferon therapies, China is poised to see an exponential growth in its hepatitis C virus treatment market, growing north of 80% in five years, according to a recent report by research firm Decision Resources
Will World's Largest HCV Population Have Access To Newest Treatments?
Merck will work with the Chinese Physician Association on an HCV awareness campaign.